Consistent with this, G15, an antagonist of GPER, enhanced migration of both HT-29 and DLD-1 CRC cells and limited the estrogenic suppression of migration (Figure 7 and Figure 8). This evidence concerns the gene GPER1 and colorectal carcinoma.